Publications by authors named "Mick Arber"

Claim this Profile
R
Reported Demographics of Primary Immunodeficiency Diseases in the United States.
Lavinia Ferrante di Ruffano, Emma Carr, Mary Edwards, Mick R Arber, Stephanie A Grilo

J Allergy Clin Immunol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.
Carl R May, Katja C Gravenhorst, Alyson Hillis, Mick Arber, Carolyn A Chew-Graham

Health Soc Care Deliv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Literature review and meta-analysis of natalizumab therapy for the treatment of highly active relapsing remitting multiple sclerosis in the 'suboptimal therapy' patient population.
Mary Chappell, Alice Sanderson, Tarunya Arun, Colin Green, Heather Davies, Mick Arber

J Neurol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of mitochondrial disease with associated seizures: systematic literature reviews of health-related quality of life, utilities, costs and healthcare resource use data.
Enrico Bertini, Emily Gregg, Chris Bartlett, Vij Senthilnathan, Mick Arber

Orphanet J Rare Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology.
Heather Davies, Mary Chappell, Yingying Wang, Angaja Phalguni, Stephanie Wake, Mick Arber

Appl Health Econ Health Policy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review on the use of biologics in adult-onset still's disease.
Bruno Fautrel, Jacoby Patterson, Catherine Bowe, Mick Arber, Julie Glanville

Semin Arthritis Rheum· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations.
James Mahon, Sophie Beale, Hayden Holmes, Mick Arber, Vladyslav Nikolayevskyy

BMC Pulm Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective coding of health care professional cancer screening behaviours and of real-world interventions designed to support them: Identifying recommendations to optimize intervention design.
Andria Hanbury, Anna Sallis, Tim Chadborn, Mick Arber, Alice Sanderson

Br J Health Psychol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Evan J Zasowski, Matteo Bassetti, Francesco Blasi, Jordi Rello, Giovanni Sotgiu, Mick R Arber

Chest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections.
Matteo Bassetti, Jordi Rello, Francesco Blasi, Herman Goossens, Giovanni Sotgiu, Mick R Arber

Int J Antimicrob Agents· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections.
Evan J Zasowski, Matteo Bassetti, Francesco Blasi, Herman Goossens, Jordi Rello, Mick R Arber

Chest· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death and dying in prehospital care: what are the experiences and issues for prehospital practitioners, families and bystanders? A scoping review.
Michelle Myall, Alison Rowsell, Susi Lund, Joanne Turnbull, Mick Arber

BMJ Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis.
Rachael McCool, Katy Wilson, Mick Arber, Kelly Fleetwood, Sydney Toupin

Mult Scler Relat Disord· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer.
Rachael McCool, Kelly Fleetwood, Julie Glanville, Mick Arber, Howard Goodall

Value Health· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS?
Mick Arber, Julie Glanville, Jaana Isojarvi, Erin Baragula, Mary Edwards

Int J Technol Assess Health Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The XprESS Multi-Sinus Dilation System for the Treatment of Chronic Sinusitis: A NICE Medical Technology Guidance.
Michelle Jenks, Iain Willits, Emily Eaton Turner, Neil Hewitt, Mick Arber

Appl Health Econ Health Policy· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectra Optia for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.
Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber

Appl Health Econ Health Policy· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Spectra Optia for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.
Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber

Appl Health Econ Health Policy· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Rachael McCool, Ian M Gould, Jacqui Eales, Teresa Barata, Mick Arber

BMC Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: HOW EXTENSIVE ARE THEIR SEARCHES?
Hannah Wood, Mick Arber, Julie M Glanville

Int J Technol Assess Health Care· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERFORMANCE OF OVID MEDLINE SEARCH FILTERS TO IDENTIFY HEALTH STATE UTILITY STUDIES.
Mick Arber, Sonia Garcia, Thomas Veale, Mary Edwards, Alison Shaw

Int J Technol Assess Health Care· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of long-term life-limiting conditions among patients and carers: what can we learn from a meta-review of systematic reviews of qualitative studies of chronic heart failure, chronic obstructive pulmonary disease and chronic kidney disease?
Carl R May, Amanda Cummings, Michelle Myall, Jonathan Harvey, Catherine Pope, Mick Arber

BMJ Open· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of 3D mammography for breast cancer screening.
Robert Hodgson, Sylvia H Heywang-Köbrunner, Susan C Harvey, Mary Edwards, Javed Shaikh, Mick Arber

Breast· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
Michelle Jenks, Joyce Craig, William Green, Neil Hewitt, Mick Arber

Appl Health Econ Health Policy· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.
Nick Freemantle, David A Ginsberg, Rachael McCool, Kelly Fleetwood, Mick Arber

BMJ Open· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis